Navigation Links
People with allergies may have lower risk of brain tumors
Date:8/3/2012

COLUMBUS, Ohio - New research adds to the growing body of evidence suggesting that there's a link between allergies and reduced risk of a serious type of cancer that starts in the brain. This study suggests the reduced risk is stronger among women than men, although men with certain allergy profiles also have a lower tumor risk.

The study also strengthens scientists' belief that something about having allergies or a related factor lowers the risk for this cancer. Because these tumors, called glioma, have the potential to suppress the immune system to allow them to grow, researchers have never been sure whether allergies reduce cancer risk or if, before diagnosis, these tumors interfere with the hypersensitive immune response to allergens.

Scientists conducting this study were able to analyze stored blood samples that were taken from patients decades before they were diagnosed with glioma. Men and women whose blood samples contained allergy-related antibodies had an almost 50 percent lower risk of developing glioma 20 years later compared to people without signs of allergies.

"This is our most important finding," said Judith Schwartzbaum, associate professor of epidemiology at Ohio State University and lead author of the study. "The longer before glioma diagnosis that the effect of allergies is present, the less likely it is that the tumor is suppressing allergies. Seeing this association so long before tumor diagnosis suggests that antibodies or some aspect of allergy is reducing tumor risk.

"It could be that in allergic people, higher levels of circulating antibodies may stimulate the immune system, and that could lower the risk of glioma," said Schwartzbaum, also an investigator in Ohio State's Comprehensive Cancer Center. "Absence of allergy is the strongest risk factor identified so far for this brain tumor, and there is still more to understand about how this association works."

Many previous studies of the link
'/>"/>

Contact: Judith Schwartzbaum
ja.schwartzbaum@gmail.com
Ohio State University
Source:Eurekalert

Page: 1 2 3 4

Related medicine news :

1. Study finds people have difficulty controlling multiple chronic conditions
2. Early treatment could mean greater earning potential for people with HIV
3. High-Tech CT Scan May Get People With Chest Pain Home Faster
4. People With Darker Skin Still at Risk for Melanoma
5. Musical glove improves sensation, mobility for people with spinal cord injury
6. Japan Nuke Disaster Will Kill Up to 1,300 People Worldwide, Study Estimates
7. Safe Composting Tips for People With Food Allergies
8. Why did Steve Jobs death affect people who never knew him?
9. Toward new drugs for the human and non-human cells in people
10. Do people want to know if they are at risk for Alzheimers disease?
11. Report Calls for Counseling Guidelines for Treating Transgender People
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/28/2015)... 2015 Could genetic code determine someone’s ... study by researchers at the Harvard T.H. Chan ... support of the Coffee and Caffeine Genetics Consortium and ... past fall, the study—one of several recent HSPH investigations ... from more than 120,000 regular coffee drinkers of European ...
(Date:3/28/2015)... 2015 Thousands of transvaginal mesh ... C.R. Bard, Inc. continue to move forward in ... Southern District of West Virginia, where Bernstein Liebhard ... Plaintiffs’ Steering Committee. According to an Order ... defendants named in those lawsuits leave to amend ...
(Date:3/28/2015)... York, NY (PRWEB) March 28, 2015 ... highlighted a problem which could prove critical to organizations ... system testing, a critical aspect of data security, is ... card industry data security report, every major category out ... scanning and penetration testing. “With all the craziness that ...
(Date:3/28/2015)... 2015 How best to treat and ... in orthopaedic medicine. While diagnostic hip injections are commonly ... pain etiology, research presented today at the American Orthopaedic ... suggests that pain relief from this diagnostic injection may ... , “Our study looked to assess if the amount ...
(Date:3/28/2015)... March 28, 2015 Andrew Hawley of Vintage ... Who psychedelic concert posters. The Who and the Doors played ... August 2, 1968. According to Hawley, “The Who toured the ... halls and college campuses. Perhaps the most famous Who poster ... Morrison and the Doors on August 2, 1968 at the ...
Breaking Medicine News(10 mins):Health News:How Coffee Habits Relate to Our Genetic Code and Enhancing the Caffeine Experience 2Health News:How Coffee Habits Relate to Our Genetic Code and Enhancing the Caffeine Experience 3Health News:Federal C.R. Bard Vaginal Mesh Lawsuits Move Forward, As Court Grants Defense Motion to Amend Responses to Master Complaint 2Health News:Federal C.R. Bard Vaginal Mesh Lawsuits Move Forward, As Court Grants Defense Motion to Amend Responses to Master Complaint 3Health News:Federal C.R. Bard Vaginal Mesh Lawsuits Move Forward, As Court Grants Defense Motion to Amend Responses to Master Complaint 4Health News:Businesses Dealing With PCI Falling Short On Regular Vulnerability Scans and Pen Testing 2Health News:Businesses Dealing With PCI Falling Short On Regular Vulnerability Scans and Pen Testing 3Health News:Businesses Dealing With PCI Falling Short On Regular Vulnerability Scans and Pen Testing 4Health News:Pain Injections for Hip Arthroscopy Patients May Not Predict Surgical Outcomes 2Health News:Avid Collector from Vintage Rock Posters, Inc. Announces His Search For Original 1960's Who Psychedelic Concert Posters. 2
... Age should not be a factor in determining ... shown that older heart transplant patients do just as ... evaluated all 275 adult patients who received a heart ... and 2000. The patients' mortality and morbidity rates were ...
... and people without liver cancer found that diabetics are stand ... the general population.// ,After taking other factors into account, ... researchers found diabetes nearly tripled the risk of liver cancer. ... for liver cancer, may be boosting the risk even further. ...
... cause skin cancer – melanoma ,however researchers as the number ... number of patients surviving the disease. // Two new studies ... kinds of cancer. In a study conducted by researchers on ... it was discovered that melanoma patients with higher levels of ...
... The most deadly form of skin cancer , advanced ... with tumor proteins, say researchers according to a recent ... with tumor antigens (called MAGE-3) might have on patients’ ... was found that injecting patients with the tumor antigens ...
... a recent study researchers focused on the use ... their impact on cholesterol and C-reactive protein levels. ... the liver that predicts inflammation in the arteries. ... important key to determining cardiovascular risk.,Researchers focused on ...
... the heart's own can, such as raising the heart rate ... a hill but researchers say a pacemaker created by // ... have shown that genetically engineered heart cells from human embryonic ... according to a new study. Researchers injected clusters of human ...
Cached Medicine News:
(Date:3/27/2015)... Biopharmaceutical Industry Leads Manufacturing Sector in R&D Spending ... as the country,s manufacturing leader in innovation and economic ... to the  analysis , the industry had the highest ... accounting for 27 percent of average annual R&D spending ... on Medicare Part D - Medicare Part D ...
(Date:3/27/2015)... 2015 The Temple Health & Bioscience District (THBD) ... building at 1802 South First St. in the Temple Medical ... City of Temple to receive funding ... Central Texas Veterans Health Care System, the new facility will ... stage biotechnology and life science companies. ...
(Date:3/27/2015)... A new report from Kalorama Information says that other countries ... Chile , Colombia and ... The healthcare research firm said that while Brazil ... American continent with a population of over 200 million people ... country,s regional economic clout does not necessarily ensure its status ...
Breaking Medicine Technology:Week in Review: The Latest from PhRMA 2Temple Health & Bioscience District Relocates, Offers Office And Lab Space To Biotech Companies 2Kalorama: Beyond Brazil, Latin American IVD Market Grows 2Kalorama: Beyond Brazil, Latin American IVD Market Grows 3Kalorama: Beyond Brazil, Latin American IVD Market Grows 4
... May 2, 2012 Zogenix, Inc. (NASDAQ: ... for the treatment of central nervous system disorders and ... New Drug Application (NDA) to the U.S. Food and ... Zogenix,s lead investigational product candidate for the treatment of ...
... 2012 Oxford BioTherapeutics (OBT) today announces ... Officer (COO) of the OBT group. In this position ... operations based in Basel, Switzerland.  The establishment of a ... global expansion as it progresses its most advanced therapeutic ...
Cached Medicine Technology:Zogenix Submits New Drug Application (NDA) to U.S. Food and Drug Administration (FDA) for Zohydro™ for Treatment of Chronic Pain 2Zogenix Submits New Drug Application (NDA) to U.S. Food and Drug Administration (FDA) for Zohydro™ for Treatment of Chronic Pain 3Zogenix Submits New Drug Application (NDA) to U.S. Food and Drug Administration (FDA) for Zohydro™ for Treatment of Chronic Pain 4Zogenix Submits New Drug Application (NDA) to U.S. Food and Drug Administration (FDA) for Zohydro™ for Treatment of Chronic Pain 5Zogenix Submits New Drug Application (NDA) to U.S. Food and Drug Administration (FDA) for Zohydro™ for Treatment of Chronic Pain 6Oxford BioTherapeutics Appoints Senior Industry Leader to Head its New Clinical Development Operations in Basel, Switzerland 2Oxford BioTherapeutics Appoints Senior Industry Leader to Head its New Clinical Development Operations in Basel, Switzerland 3
... Plus Retics is a 5-part differential control ... the Abbott CELL-DYN 3200, 3500, 3700 and ... contains nucleated red blood cells that can ... 4000. The assay contains automated and manual ...
... Sickle-Chex is a positive and negative whole ... of Hemoglobin S in solubility tests and ... SICKLEDEX and other manufacturers' solubility kits. ... squeeze dropper vial. The vial dispenses an ...
... blood hematology control manufactured specifically for the ... the Coulter AcT5diff instruments. The composition of ... differential, positioning the populations within the limitations ... product offers 105-day closed-vial stability and 14-day ...
... STaK-Chex, a whole blood assayed hematology ... five-part white cell differential available with the ... unique product has 14-day open-vial stability, 105-day ... normal and high levels. The 4.0ml pierceable ...
Medicine Products: